Informations sur le produit
Nom :
rel-(R,R)-voriconazole
Synonymes :
- rel-(a-R,b-S)-a-(2,4-difluorophenyl)-5-fluoro-b-methyl-a-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
- 2-(2,4-Difluorophenyl)-3-(5-Fluoropyrimidin-4-Yl)-1-(1H-1,2,4-Triazol-1-Yl)Butan-2-Ol
- (2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol
- (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
- (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol L(-)-Camphorsulfonate
Description :
Voriconazole is a triazole antifungal agent used for the treatment of a variety of fungal infections. It inhibits the synthesis of ergosterol, which is an essential component of fungal cell membranes. Voriconazole binds to the cytochrome P450 system, stabilizing it and preventing its inactivation by other drugs. This drug can be administered intravenously or intravitreally. Voriconazole also has a stabilizing effect on protein and lipid-based formulations and is suitable for freeze-dried or solubilized preparations. It has been shown that voriconazole injection compositions are stable at room temperature for up to four weeks when stored in amber glass vials, although they should be protected from light and moisture.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
349.31 g/mol
Formule :
C16H14F3N5O
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
